Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30015051HIVENSG00000102524.12protein_codingTNFSF13BNoNo10673Q9Y275
TVIS30015052HIVENSG00000102524.12protein_codingTNFSF13BNoNo10673Q9Y275
TVIS30015053HIVENSG00000102524.12protein_codingTNFSF13BNoNo10673Q9Y275
TVIS30015045HIVENSG00000102524.12protein_codingTNFSF13BNoNo10673Q9Y275
TVIS30015047HIVENSG00000102524.12protein_codingTNFSF13BNoNo10673Q9Y275
TVIS30021259HIVENSG00000102524.12protein_codingTNFSF13BNoNo10673Q9Y275
TVIS30021260HIVENSG00000102524.12protein_codingTNFSF13BNoNo10673Q9Y275
TVIS44014760HTLV-1ENSG00000102524.12protein_codingTNFSF13BNoNo10673Q9Y275
TCGA Plot Options
Drug Information
GeneTNFSF13B
DrugBank IDDB08879
Drug NameBelimumab
Target IDBE0000999
UniProt IDQ9Y275
Regulation Typeantibody
PubMed IDs29396833
CitationsBlair HA, Duggan ST: Belimumab: A Review in Systemic Lupus Erythematosus. Drugs. 2018 Mar;78(3):355-366. doi: 10.1007/s40265-018-0872-z.
GroupsApproved
Direct ClassificationPeptides
SMILES
Pathways
PharmGKB
ChEMBLCHEMBL1789843